Teva sets guidance for three tranche euro-denominated M&A bond

July 20, 2016 10:12 AM

27 0

LONDON, July 20 (IFR) - Teva Pharmaceutical has set guidance for a multi-tranche bond issue to help fund its US$40.5bn acquisition of Actavis Generics, according to a lead bank.

Guidance was set at mid-swaps plus 75bp area for a four-year tranche expected size 1.5bn minimum, at mid-swaps plus 115bp area for an eight-year expected 1.25bn minimum, and a 12-year expected 750m tranche at plus 135bp area.

Read more

To category page